Search

everythinglearnresearchcommunity

for

Search:↓

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.